Skip to content

H2020FP7HORIZON

Eli Lilly and Company Ltd

Country
GBUnited Kingdom
Defence projects
0
Projects, all programmes
70
As coordinator
0
EU contribution (CORDIS)
EUR 1,853,320
Active
2009 to 2025

Projects

70 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
c4cconect4children (COllaborative Network for European Clinical Trials For Children)H20202018ParticipantEUR 0
EHDENEuropean Health Data and Evidence NetworkH20202018ParticipantEUR 0
TOBeATPAINTargeting neuroinflammation to combat pathological pain in neurodegenerative diseases and chronic pain syndromesH20202018ParticipantEUR 91,096
GetReal InitiativeThe GetReal InitiativeH20202018ParticipantEUR 0
DO-ITBig Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055H20202017ParticipantEUR 0
ITCC-P4ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064H20202017ParticipantEUR 0
IMPRiNDInhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060H20202017ParticipantEUR 0
TransQSTTranslational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030H20202017ParticipantEUR 0
LITMUSLiver Investigation: Testing Marker Utility in SteatohepatitisH20202017ParticipantEUR 0
BEAt-DKDBiomarker Enterprise to Attack DKD - Sofia ref.: 115974H20202016ParticipantEUR 0
PREFERPatient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966H20202016ParticipantEUR 0
RHAPSODYAssessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881H20202016ParticipantEUR 0
MOPEADModels Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985H20202016ParticipantEUR 0
PRISMPsychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916H20202016ParticipantEUR 0
PHAGOInflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976H20202016ParticipantEUR 0
ROADMAPReal world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020H20202016ParticipantEUR 0
EPADEuropean Prevention of Alzheimer’s Dementia ConsortiumFP72015ParticipantNot stated
REGAINREgeneration of inner ear hair cells with GAmma-secretase INhibitors to regain hearing in patients with sensorineural hearing lossH20202015ParticipantEUR 1,347,363
INNODIATranslational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797H20202015ParticipantEUR 0
ADAPT-SMARTAccelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890H20202015ParticipantEUR 0

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.